People Briefs

Harvey M. Florman has been appointed to the faculty of the Worcester Foundation for Experimental Biology in Shrewsbury, Mass., as a staff scientist. He comes from the University of Wisconsin, where he was a senior scientist. Florman is a reproductive biologist with particular interest and expertise in the study of sperm-egg interactions. He holds a grant from the National Institutes of Health for a research program concerned with sperm binding receptors on mammalian eggs, and will be affiliated

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Harvey M. Florman has been appointed to the faculty of the Worcester Foundation for Experimental Biology in Shrewsbury, Mass., as a staff scientist. He comes from the University of Wisconsin, where he was a senior scientist. Florman is a reproductive biologist with particular interest and expertise in the study of sperm-egg interactions. He holds a grant from the National Institutes of Health for a research program concerned with sperm binding receptors on mammalian eggs, and will be affiliated with the Worcester Foundation's Male Fertility Program.

The Worcester Foundation, best known for the development of the birth control pill, is currently focusing on cancer and cell biology, neurobiology, and endocrine-reproductive biology. Florman is a graduate of Rutgers University and received his Ph.D. from the University of Pennsylvania. He completed postdoctoral training at Harvard Medical School.

Denning's column, "The Science of Computing," appears regularly in American Scientist. He earned his B.E.E. degree ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies